| HGNC Family | G protein-coupled receptors |
| Name | G protein-coupled receptor 39 |
| Description | This gene is a member of the ghrelin receptor family and encodes a rhodopsin-type G-protein-coupled receptor (GPCR). The encoded protein is involved in zinc-dependent signaling in epithelial tissue in intestines, prostate and salivary glands. The protein may also be involved in the pathophysiology of depression. [provided by RefSeq, Jun 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n GPR39 is a multifunctional, constitutively active G protein–coupled receptor that has emerged as a critical extracellular zinc sensor with diverse roles in physiology and disease. Early investigations proposed that GPR39 might mediate the anorexigenic effects of obestatin—a peptide encoded by the ghrelin gene—but subsequent studies have demonstrated that zinc, rather than obestatin, is the more consistent activator of its signaling pathways."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": " Activated by extracellular Zn²⁺, GPR39 engages several downstream effectors—including the G<sub>q</sub>/phospholipase C cascade, inositol phosphate turnover, cAMP‐ and serum response element–dependent transcription, and pathways mediated by G<sub>12/13</sub>–Rho kinase—to modulate cellular function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "10"}]}, {"type": "t", "text": " In the gastrointestinal tract, GPR39 influences motility, gastric emptying, and the maintenance of epithelial barrier integrity by regulating the expression of tight junction proteins such as occludin, thereby contributing to mucosal repair and homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "14"}]}, {"type": "t", "text": " In the endocrine pancreas, GPR39 is expressed in insulin‐producing β‐cells where it helps regulate islet architecture, insulin secretion, and glucose tolerance, suggesting that modulation of its activity could have therapeutic value for type 2 diabetes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "18"}]}, {"type": "t", "text": " Moreover, in the central nervous system GPR39 contributes to neuronal excitability and survival by modulating the CREB–BDNF cascade and influencing inhibitory neurotransmission (for example, via up‐regulation of KCC2), with receptor deficiency being linked to depressive‐ and anxiety‐like behaviors and altered monoaminergic tone."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "21"}]}, {"type": "t", "text": " In addition, zinc–GPR39 signaling promotes cellular repair in epithelia such as keratinocytes, where it enhances Ca²⁺ responses and survival mechanisms involved in wound healing."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}, {"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Recent evidence also implicates aberrant GPR39 expression in oncogenesis; overexpression in esophageal and oral squamous cell carcinomas promotes cell proliferation, cell cycle progression, and epithelial–mesenchymal transition through modulation of cyclins and PI3K/AKT/mTOR signaling, while microRNAs targeting GPR39 can attenuate these tumorigenic processes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "25"}]}, {"type": "t", "text": " Finally, population‐based genetic studies have begun to explore associations between GPR39 polymorphisms and migraine susceptibility, further underscoring the receptor’s broad physiological impact."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": " Collectively, these findings illustrate that GPR39 functions as a zinc sensor that orchestrates a wide range of cellular responses in the gastrointestinal, endocrine, nervous, and neoplastic systems, making it an attractive target for therapeutic intervention in metabolic, neuropsychiatric, and cancer disorders.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jian V Zhang, Pei-Gen Ren, Orna Avsian-Kretchmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1117255"}], "href": "https://doi.org/10.1126/science.1117255"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16284174"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16284174"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Birgitte Holst, Kristoffer L Egerod, Enrico Schild, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR39 signaling is stimulated by zinc ions but not by obestatin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2006-0933"}], "href": "https://doi.org/10.1210/en.2006-0933"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16959833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16959833"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Erwin Lauwers, Bart Landuyt, Lutgarde Arckens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Obestatin does not activate orphan G protein-coupled receptor GPR39."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.09.141"}], "href": "https://doi.org/10.1016/j.bbrc.2006.09.141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17054911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17054911"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jian V Zhang, Holger Jahr, Chin-Wei Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0569"}], "href": "https://doi.org/10.1210/me.2007-0569"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18337590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18337590"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "M J Iglesias, A Salgado, R Piñeiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Endocrinol Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/BF03346330"}], "href": "https://doi.org/10.1007/BF03346330"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17646721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17646721"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Birgitte Holst, Nicholas D Holliday, Anders Bach, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common structural basis for constitutive activity of the ghrelin receptor family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M407676200"}], "href": "https://doi.org/10.1074/jbc.M407676200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15383539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15383539"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Birgitte Holst, Rie Nygaard, Louise Valentin-Hansen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.064725"}], "href": "https://doi.org/10.1074/jbc.M109.064725"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19920139"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19920139"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Nicholas D Holliday, Birgitte Holst, Elena A Rodionova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0254"}], "href": "https://doi.org/10.1210/me.2007-0254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17717076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17717076"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "M R Morris, D Gentle, M Abdulrahman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6604180"}], "href": "https://doi.org/10.1038/sj.bjc.6604180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18195710"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18195710"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Shin-ichiro Yasuda, Takahiro Miyazaki, Kouji Munechika, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Recept Signal Transduct Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/10799890701506147"}], "href": "https://doi.org/10.1080/10799890701506147"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17885920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17885920"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Dieder Moechars, Inge Depoortere, Benoit Moreaux, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2006.07.009"}], "href": "https://doi.org/10.1053/j.gastro.2006.07.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17030183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17030183"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "L Cohen, I Sekler, M Hershfinkel "}, {"type": "b", "children": [{"type": "t", "text": "The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2014.262"}], "href": "https://doi.org/10.1038/cddis.2014.262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24967969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24967969"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Laxmi Sunuwar, Michal Medini, Limor Cohen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Philos Trans R Soc Lond B Biol Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1098/rstb.2015.0420"}], "href": "https://doi.org/10.1098/rstb.2015.0420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27377730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27377730"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Limor Cohen, Hagit Azriel-Tamir, Natan Arotsker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Zinc sensing receptor signaling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0035482"}], "href": "https://doi.org/10.1371/journal.pone.0035482"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22545109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22545109"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Birgitte Holst, Kristoffer L Egerod, Chunyu Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2008-1250"}], "href": "https://doi.org/10.1210/en.2008-1250"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19213833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19213833"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Riccarda Granata, Alessandra Baragli, Fabio Settanni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unraveling the role of the ghrelin gene peptides in the endocrine pancreas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Endocrinol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/JME-10-0019"}], "href": "https://doi.org/10.1677/JME-10-0019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20595321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20595321"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Frédéric Tremblay, Ann-Marie T Richard, Sarah Will, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2008-1251"}], "href": "https://doi.org/10.1210/en.2008-1251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19213841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19213841"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "P J Verhulst, A Lintermans, S Janssen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroendocrinol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2826.2011.02132.x"}], "href": "https://doi.org/10.1111/j.1365-2826.2011.02132.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21470317"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21470317"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Katarzyna Młyniec, Bogusława Budziszewska, Birgitte Holst, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Neuropsychopharmacol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ijnp/pyu002"}], "href": "https://doi.org/10.1093/ijnp/pyu002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25609596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25609596"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Katarzyna Młyniec, Nicolas Singewald, Birgitte Holst, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Affect Disord (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jad.2014.11.033"}], "href": "https://doi.org/10.1016/j.jad.2014.11.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25490458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25490458"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Katarzyna Młyniec, Magdalena Gaweł, Tadeusz Librowski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Investigation of the GPR39 zinc receptor following inhibition of monoaminergic neurotransmission and potentialization of glutamatergic neurotransmission."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res Bull (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainresbull.2015.04.005"}], "href": "https://doi.org/10.1016/j.brainresbull.2015.04.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25917396"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25917396"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Haleli Sharir, Anna Zinger, Andrey Nevo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.107490"}], "href": "https://doi.org/10.1074/jbc.M110.107490"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20522546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20522546"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Fajun Xie, Haibo Liu, Ying-Hui Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-11-86"}], "href": "https://doi.org/10.1186/1471-2407-11-86"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21352519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21352519"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Y Jiang, T Li, Y Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dent Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0022034520915877"}], "href": "https://doi.org/10.1177/0022034520915877"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32325008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32325008"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Liankang Sun, Liang Wang, Tianxiang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14705"}], "href": "https://doi.org/10.1111/jcmm.14705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31576658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31576658"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yu-Hsiang Ling, Shih-Pin Chen, Cathy Shen-Jang Fann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRPM8 genetic variant is associated with chronic migraine and allodynia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Headache Pain (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s10194-019-1064-2"}], "href": "https://doi.org/10.1186/s10194-019-1064-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31842742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31842742"}]}]}]}
|
| Proteins | GPR39_HUMAN |
| NCBI Gene ID | 2863 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
GPR39 has 5,909 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 107 datasets.
Click the + buttons to view associations for GPR39 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of GPR39 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of GPR39 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of GPR39 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of GPR39 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of GPR39 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of GPR39 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of GPR39 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of GPR39 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with GPR39 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of GPR39 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of GPR39 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of GPR39 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of GPR39 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing GPR39 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with GPR39 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with GPR39 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with GPR39 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with GPR39 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with GPR39 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with GPR39 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by GPR39 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with GPR39 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with GPR39 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with GPR39 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with GPR39 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with GPR39 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at GPR39 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of GPR39 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of GPR39 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing GPR39 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with GPR39 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with GPR39 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of GPR39 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with GPR39 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing GPR39 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of GPR39 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of GPR39 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of GPR39 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of GPR39 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of GPR39 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of GPR39 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving GPR39 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing GPR39 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by GPR39 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by GPR39 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by GPR39 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of GPR39 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of GPR39 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of GPR39 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding GPR39 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with GPR39 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with GPR39 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with GPR39 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of GPR39 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of GPR39 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of GPR39 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of GPR39 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with GPR39 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by GPR39 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for GPR39 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of GPR39 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of GPR39 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of GPR39 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of GPR39 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of GPR39 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with GPR39 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of GPR39 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of GPR39 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain GPR39 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by GPR39 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting GPR39 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of GPR39 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by GPR39 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of GPR39 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of GPR39 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing GPR39 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for GPR39 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of GPR39 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of GPR39 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving GPR39 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving GPR39 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving GPR39 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving GPR39 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of GPR39 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at GPR39 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of GPR39 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of GPR39 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of GPR39 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of GPR39 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of GPR39 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of GPR39 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of GPR39 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of GPR39 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of GPR39 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of GPR39 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of GPR39 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of GPR39 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with GPR39 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with GPR39 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving GPR39 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving GPR39 protein from the WikiPathways Pathways 2024 dataset. | |